RxDoctor Payments Data

Blair Ardman, MD

Hematology & Oncology · Lowell, MANPI 1578510160

Payments from drug & device makers

$28,231in general payments, 2019–2025

Across 57 payments — averaging $495.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$28K
  • Johnson & Johnson$137
  • AstraZeneca$87
  • E.r. Squibb & Sons, L.L.C.$85
  • Daiichi Sankyo Inc.$37
  • Merck$35
  • plus $151 from 7 others

What the payments were for

  • Food & beverage$56196%
  • Education$214%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$28,231 in reported general payments places this provider in the 55th percentile of 374 hematology & oncology providers in Massachusetts.

See all hematology & oncology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$61,138
Medicare patients
242
Services billed
750

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other hematology & oncology in Lowell

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →